Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 20.15 Billion CNY | 8.34% |
| 2022 | 18.6 Billion CNY | 17.21% |
| 2021 | 15.87 Billion CNY | 7.21% |
| 2020 | 14.8 Billion CNY | 23.83% |
| 2019 | 11.95 Billion CNY | 22.36% |
| 2018 | 9.77 Billion CNY | 29.37% |
| 2017 | 7.55 Billion CNY | 20.31% |
| 2016 | 6.27 Billion CNY | 45.85% |
| 2015 | 4.3 Billion CNY | 15.24% |
| 2014 | 3.73 Billion CNY | 38.47% |
| 2013 | 2.69 Billion CNY | 32.94% |
| 2012 | 2.02 Billion CNY | 28.96% |
| 2011 | 1.57 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 20.64 Billion CNY | 2.41% |
| 2024 Q2 | 21.86 Billion CNY | 5.88% |
| 2024 Q3 | 22.03 Billion CNY | 0.79% |
| 2023 FY | 20.15 Billion CNY | 8.34% |
| 2023 Q1 | 18.9 Billion CNY | 1.6% |
| 2023 Q3 | 20.73 Billion CNY | -0.79% |
| 2023 Q4 | 20.15 Billion CNY | -2.78% |
| 2023 Q2 | 20.9 Billion CNY | 10.56% |
| 2022 Q4 | 18.6 Billion CNY | -3.31% |
| 2022 Q2 | 18.07 Billion CNY | 6.58% |
| 2022 Q1 | 16.95 Billion CNY | 6.83% |
| 2022 Q3 | 19.24 Billion CNY | 6.47% |
| 2022 FY | 18.6 Billion CNY | 17.21% |
| 2021 FY | 15.87 Billion CNY | 7.21% |
| 2021 Q1 | 15.11 Billion CNY | 2.05% |
| 2021 Q2 | 16.31 Billion CNY | 7.98% |
| 2021 Q3 | 16.65 Billion CNY | 2.05% |
| 2021 Q4 | 15.87 Billion CNY | -4.67% |
| 2020 Q4 | 14.8 Billion CNY | 3.89% |
| 2020 Q1 | 13.36 Billion CNY | 11.73% |
| 2020 FY | 14.8 Billion CNY | 23.83% |
| 2020 Q2 | 13.22 Billion CNY | -1.03% |
| 2020 Q3 | 14.25 Billion CNY | 7.79% |
| 2019 Q2 | 12.06 Billion CNY | 7.32% |
| 2019 FY | 11.95 Billion CNY | 22.36% |
| 2019 Q4 | 11.95 Billion CNY | -6.02% |
| 2019 Q3 | 12.72 Billion CNY | 5.48% |
| 2019 Q1 | 11.23 Billion CNY | 15.01% |
| 2018 Q1 | 8.27 Billion CNY | 9.53% |
| 2018 Q4 | 9.77 Billion CNY | 7.65% |
| 2018 FY | 9.77 Billion CNY | 29.37% |
| 2018 Q3 | 9.07 Billion CNY | 6.95% |
| 2018 Q2 | 8.48 Billion CNY | 2.59% |
| 2017 Q4 | 7.55 Billion CNY | 4.02% |
| 2017 FY | 7.55 Billion CNY | 20.31% |
| 2017 Q3 | 7.26 Billion CNY | 8.7% |
| 2017 Q2 | 6.68 Billion CNY | 2.19% |
| 2017 Q1 | 6.53 Billion CNY | 4.13% |
| 2016 FY | 6.27 Billion CNY | 45.85% |
| 2016 Q4 | 6.27 Billion CNY | 9.64% |
| 2016 Q2 | 5.65 Billion CNY | -2.71% |
| 2016 Q1 | 5.81 Billion CNY | 35.06% |
| 2016 Q3 | 5.72 Billion CNY | 1.23% |
| 2015 Q2 | 3.91 Billion CNY | 7.13% |
| 2015 Q4 | 4.3 Billion CNY | 3.54% |
| 2015 Q3 | 4.15 Billion CNY | 6.16% |
| 2015 Q1 | 3.65 Billion CNY | -2.13% |
| 2015 FY | 4.3 Billion CNY | 15.24% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 3.32 Billion CNY | 8.13% |
| 2014 Q4 | 3.73 Billion CNY | 12.36% |
| 2014 FY | 3.73 Billion CNY | 38.47% |
| 2014 Q2 | 3.07 Billion CNY | 0.0% |
| 2013 FY | 2.69 Billion CNY | 32.94% |
| 2013 Q4 | 2.69 Billion CNY | 0.0% |
| 2012 FY | 2.02 Billion CNY | 28.96% |
| 2011 FY | 1.57 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 37.4 Billion CNY | 46.112% |
| Liaoning Cheng Da Co., Ltd. | 46.9 Billion CNY | 57.017% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 211.97 Billion CNY | 90.49% |